New Atlas

Protein infusion could reduce heart failure risk after heart attack

Heart disease is the biggest killer in the Western world. A part of the problem is that even if one survives a heart attack, damage to the heart muscle results in the formation of thick scar tissue ...
TCTMD

CADUCEUS: Autologous Stem Cells Safely Reverse Some MI Damage

In patients with a recent myocardial infarction, infusion of their own cardiac progenitor cells safely reduces scar tissue while increasing viable myocardium over 1 year, according to a first-in-man ...
Business Wire

Capillary Biomedical Receives FDA Approval to Begin Pivotal Trial of Its SteadiFlow Seven-Day-Wear Infusion Set Technology

IRVINE, Calif.--(BUSINESS WIRE)--Medical device developer Capillary Biomedical, Inc. (CapBio) has announced that it has received investigational device exemption (IDE) approval from the U.S. Food and ...
Business Wire

Capillary Biomedical Reports Best-in-Class Clinical Feasibility Results for its SteadiFlow Seven-Day-Wear Infusion Set Technology at ADA Scientific Sessions

IRVINE, Calif.--(BUSINESS WIRE)--Medical device developer Capillary Biomedical, Inc. (CapBio) has presented highly favorable clinical feasibility study results for its SteadiFlow cannula technology at ...